Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd

This study tests an experimental treatment called SYS6055 in adults with aggressive B-cell lymphoma that has returned or not responded to standard therapy. The treatment uses specially modified immune cells (CAR-T cells) to target and attack cancer cells. The main goals are to ch…